Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy
05 avr. 2022 08h00 HE
|
Sema4
STAMFORD, Conn., April 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the...
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
14 mars 2022 16h05 HE
|
Sema4
37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue...
Childhood Trauma and Genetics Linked to Increased Obesity Risk
09 mars 2022 13h00 HE
|
Desert Research Institute
Reno, Nev., March 09, 2022 (GLOBE NEWSWIRE) -- New research from the Healthy Nevada Project® found associations between genetics, obesity, and childhood trauma, linking social health determinants,...
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
08 mars 2022 08h00 HE
|
Sema4
STAMFORD, Conn., March 08, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, has been named to Fast Company’s prestigious annual...
The Path to Seedless Cannabis: How Triploid Sterile Varieties Can Help Farmers Stop Worrying About Unwanted Pollen
24 févr. 2022 17h34 HE
|
Dark Heart Industries
DAVIS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Dark Heart Nursery Executive Speaking Alert. What: Cutting-edge cannabis science content. Richard Philbrook, a leading expert on molecular biology,...
Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24 févr. 2022 09h00 HE
|
Myriad Genetics, Inc.
Highlights: Strong business performance despite COVID-19 headwindsRevenue of $160.8 million in the fourth quarter and $690.6 million for the year ended Dec. 31, 2021, up 4% and 24%, respectively...
SelfDecode Celebrates Black History Month by Addressing the Underrepresentation of African Americans in Genetics Research
23 févr. 2022 10h00 HE
|
SelfDecode
MIAMI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- It is a well known problem that African Americans, and other minorities, suffer from a lack of representation within genetic research and databases. This...
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
22 févr. 2022 08h00 HE
|
Sema4
STAMFORD, Conn. and BOSTON and TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, and BioSymetrics, a...
Positive Results for Lipid inCode® in NHS Clinical Study
15 févr. 2022 02h00 HE
|
GENinCode Plc
OXFORD, England, Feb. 15, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion...
Sema4 to Participate at Two Upcoming Investor Conferences in February
03 févr. 2022 16h05 HE
|
Sema4
STAMFORD, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will...